Contact Us
About Us
Our Company
Our Leadership
Global Collaborations
Areas of Focus
Vaccines
Other Diseases
Pipeline
Science & Technology
Our Technology
COVID-19 Response
Manufacturing
Publications
Careers
Our Culture
Our Benefits
Our Positions
Investors
Corporate Governance
HKEX Filings
Financial Reports
IR Events
Presentations
IR Contact
News & Media
Company News
Media coverage
Contact Us
English
English
中文
Clover Biopharmaceuticals(HKEX: 2197)
Investor Relations
Corporate Governance
HKEX Filings
Financial Reports
IR Events
Presentations
IR Contact
HKEX Filings
All Years
2024 (2)
Search
Note: Please refer any disclosure documents of the listco to Hong Kong Stock Exchange (SEHK) website
Jul 3, 2024
Monthly Return of Equity Issuer on Movements in Securities for the Month ended June 30, 2024
Jun 20, 2024
FIFTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
1
About Us
Areas of Focus
Pipeline
Science & Technology
Careers
Investors
News & Media
Contact Us
Terms of Use
Privacy Policy
Community Guidelines
©2023 Clover Biopharmaceuticals
蜀ICP备08004531号-1
川公网安备51019002003830号